North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type (Dry AMD, and Wet AMD), By Region (North America and Europe), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Drug Type (Bevacizumab (Avastin), Aflibercept (Eylea), Brolucizumab (Beovu), Ranibizumab (Lucentis), Pegaptanib (Macugen), Verteporfin (Visudyne), Supplements, and Others), and is approximated to be worth around US$ 9,958.7 million in 2020 and is expected to manifest a CAGR of 6.1% over the forecast period (2020-2027), as mentioned in a new report published by Coherent Market Insights.
Request Here Sample with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/4171
Driver
Rising incidences of age-related macular degeneration are expected to propel growth of the Age-related Macular Degeneration (AMD) therapeutics market over the forecast period. As per the publication from the European Society of Retina Specialist, about 22 million citizens of most populated nations of Europe i.e., France, Germany, Italy, the U.K., and Spain, and another 34 million people from the European Union (EU) were suffering from AMD condition in 2017.
Impact of COVID-19 epidemic
Due to the national lockdowns in major regions, the medium and small-scale ophthalmology practices were totally halted with only large ophthalmology practices been active for to deal with emergency cases. This has significantly decreased the number of footfalls of ophthalmology clinics.
Although, healthcare practitioners are opting for tele-health options for diagnosing the cancer patients with social distancing measures to tackle COVID-19 epidemic, hence not compromise with the health of patients. For consultations with doctors, the patients can place online appointments. The following measures are taken by the healthcare providers to minimized the transmission of COVID-19 pandemic,
For people entering the hospitals, the screening is to be performed in suspicion of COVID-19 symptoms.
Patients are to be encouraged by the healthcare providers for scheduling their appointments through telemedicine platforms.
Hospitals will have prohibition on visitor entry with only emergency cases being diagnosed.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4171
The focus of the key companies on adoption of inorganic strategies such as partnerships, dealings, agreements, and collaborations to enhance the portfolio of their products and build-up their market credibility. In September 2019, the Boehringer Ingelheim had partnered with Inflammasome Therapeutics in a co-development and licensing deal which aimed for developing three therapies that focused on retinal disorders including diabetic retinopathy, diabetic macular edema (DMA), and AMD.
Key Takeaways of the North America & Europe Age-related Macular Degeneration (AMD) Therapeutics Market:
Due to the launches of AMD therapeutics by key companies, the North America and Europe Age-related Macular Degeneration (AMD) therapeutics market is expected to manifest a CAGR of 6.1% over the forecast period. In June 2016, the Intas Pharmaceuticals had launched RAZUMAB which was biologically similar to Lucentis (Ranibizumab) which is suitable for treatment of wet AMD.
Due to rise in research and development for treatment of AMD disorders by key companies, the dry AMD segment contributes the largest share in the market in 2019 considering the type of disease. In October 2019, the medical organization, LumiThera Inc., had initiated the enrolment of patients for a multi-year clinical study in the U.S., LIGHTSITE III for treating dry AMD.
According to the type of drug, the Aflibercept (Eylea) segment had contributed the largest share in the market due to accelerated research and development work by key companies in 2019. In February 2019, Bayer AG and Regeneron Pharmaceuticals, Inc., had announced the execution of two Phase III studies, PULSAR and PHOTON for evaluating the prolonged intervals of the treatment with aflibercept 8mg formulation for diagnosing wet AMD.
Major companies contributing in the North America & Europe Age-related Macular Degeneration (AMD) therapeutics market include F. Hoffmann-La Roche AG, Bausch Health Companies Inc., Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Novartis AG, Bayer AG, and Valeant Pharmaceuticals International, Inc.
Reasons to Purchase this Report
• Current and future of global North America & Europe Age-related Macular Degeneration Therapeutics market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- PEST Analysis
- Market Dynamics
- North America & Europe Age-related Macular Degeneration Therapeutics Market – Impact of Coronavirus (Covid-19) Pandemic
- Impact assessment
- Pre COVID-19 Market Scenario
- Post COVID-19 Market Scenario
- Government measures to combat COVID-19
- North America & Europe Age-related Macular Degeneration Therapeutics Market, By Disease Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Dry AMD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Wet AMD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- North America & Europe Age-related Macular Degeneration Therapeutics Market, By Drug Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Aflibercept (Eylea)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Ranibizumab (Lucentis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Bevacizumab (Avastin)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Pegaptanib (Macugen)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Verteporfin (Visudyne)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brolucizumab (Beovu)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- North America & Europe Age-related Macular Degeneration Therapeutics Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- North America & Europe Age-related Macular Degeneration Therapeutics Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Disease Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Novartis AG
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bausch Health Companies Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hoffmann-La Roche AG
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Valeant Pharmaceuticals International, Inc.
- Company Overview
- Device Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837